» Articles » PMID: 32132596

Pressurized Carbon Dioxide As a Potential Tool for Decellularization of Pulmonary Arteries for Transplant Purposes

Overview
Journal Sci Rep
Specialty Science
Date 2020 Mar 6
PMID 32132596
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular bio-scaffolds produced from decellularized tissue offer a promising material for treatment of several types of cardiovascular diseases. These materials have the potential to maintain the functional properties of the extracellular matrix (ECM), and allow for growth and remodeling in vivo. The most commonly used methods for decellularization are based on chemicals and enzymes combinations, which often damage the ECM and cause cytotoxic effects in vivo. Mild methods involving pressurized CO-ethanol (EtOH)-based fluids, in a supercritical or near supercritical state, have been studied for decellularization of cardiovascular tissue, but results are controversial. Moreover, data are lacking on the amount and type of lipids remaining in the tissue. Here we show that pressurized CO-EtOH-HO fluids (average molar composition, Χ 0.91) yielded close to complete removal of lipids from porcine pulmonary arteries, including a notably decrease of pro-inflammatory fatty acids. Pressurized CO-limonene fluids (Χ 0.88) and neat supercritical CO (scCO) achieved the removal of 90% of triacylglycerides. Moreover, treatment of tissue with pressurized CO-limonene followed by enzyme treatment, resulted in efficient DNA removal. The structure of elastic fibers was preserved after pressurized treatment, regardless solvent composition. In conclusion, pressurized CO-ethanol fluids offer an efficient tool for delipidation in bio-scaffold production, while pressurized CO-limonene fluids facilitate subsequent enzymatic removal of DNA.

Citing Articles

Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations.

Liu J, Song Q, Yin W, Li C, An N, Le Y Exploration (Beijing). 2025; 5(1):20230078.

PMID: 40040827 PMC: 11875452. DOI: 10.1002/EXP.20230078.


Advances and Challenges of Tissue Vascular Scaffolds and Supercritical Carbon Dioxide Technology in Cardiovascular Diseases.

Tseng H, Lin Y, Sung S, Tsai Y, Liu C, Hsu P Tissue Eng Regen Med. 2025; .

PMID: 40029563 DOI: 10.1007/s13770-025-00710-3.


Surfactant-Free Decellularization of Porcine Auricular Cartilage Using Liquefied Dimethyl Ether and DNase.

Kanda H, Oya K, Wahyudiono , Goto M Materials (Basel). 2023; 16(8).

PMID: 37110010 PMC: 10146022. DOI: 10.3390/ma16083172.


Application of decellularization-recellularization technique in plastic and reconstructive surgery.

Shang Y, Wang G, Zhen Y, Liu N, Nie F, Zhao Z Chin Med J (Engl). 2023; 136(17):2017-2027.

PMID: 36752783 PMC: 10476794. DOI: 10.1097/CM9.0000000000002085.


Preparation and Use of Decellularized Extracellular Matrix for Tissue Engineering.

McInnes A, Moser M, Chen X J Funct Biomater. 2022; 13(4).

PMID: 36412881 PMC: 9680265. DOI: 10.3390/jfb13040240.


References
1.
Benjamin E, Blaha M, Chiuve S, Cushman M, Das S, Deo R . Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017; 135(10):e146-e603. PMC: 5408160. DOI: 10.1161/CIR.0000000000000485. View

2.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M . 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33):3021-3104. DOI: 10.1093/eurheartj/ehy339. View

3.
Michelakis E . Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implications. Circ Res. 2006; 98(2):172-5. DOI: 10.1161/01.RES.0000204572.65400.a5. View

4.
El-Sherbiny I, Yacoub M . Hydrogel scaffolds for tissue engineering: Progress and challenges. Glob Cardiol Sci Pract. 2014; 2013(3):316-42. PMC: 3963751. DOI: 10.5339/gcsp.2013.38. View

5.
Pashneh-Tala S, MacNeil S, Claeyssens F . The Tissue-Engineered Vascular Graft-Past, Present, and Future. Tissue Eng Part B Rev. 2015; 22(1):68-100. PMC: 4753638. DOI: 10.1089/ten.teb.2015.0100. View